The potential of metabolic fingerprinting as a tool for the modernisation of TCM preparations

Abstract

A vast majority Chinese herbal medicines (CHM) are traditionally administered as individually prepared water decoctions (tang) which are rather complicated in practice and their dry extracts show technological problems that hamper straight production of more convenient application forms. Modernised extraction procedures may overcome these difficulties but there is lack of clinical evidence supporting their therapeutic equivalence to traditional decoctions and their quality can often not solely be attributed to the single marker compounds that are usually used for chemical extract optimisation. As demonstrated by the example of the rather simple traditional TCM formula Danggui Buxue Tang, both the chemical composition and the biological activity of extracts resulting from traditional water decoction are influenced by details of the extraction procedure and especially involve pharmacokinetic synergism based on co-extraction. Hence, a more detailed knowledge about the traditional extracts' chemical profiles and their impact on biological activity is desirable in order to allow the development of modernised extracts that factually contain the whole range of compounds relevant for the efficacy of the traditional application. We propose that these compounds can be identified by metabolomics based on comprehensive fingerprint analysis of different extracts with known biological activity. TCM offers a huge variety of traditional products of the same botanical origin but with distinct therapeutic properties, like differentially processed drugs and special daodi qualities. Through this variety, TCM gives an ideal field for the application of metabolomic techniques aiming at the identification of active constituents.

Perspectives and Challenges in Molecular-Based Diagnostics and Personalized Treatment for Recurrent High-Grade Gliomas

“…In fact, natural products or natural product-derived molecules constitute a major part of the FDA approved anti-cancer agents with Taxanes, Vinca alkaloids, podopyllotoxins and camptothecin being only some of the examples. Considering that molecular targets for many natural products and their derivatives are known, molecular profiling offers the possibility for molecular-based prediction of potentially effective natural products using the drug-repositioning approach [88]. On the experimental level pharmaceutical databases can be screened to identify compounds known to interfere with these pathways to include such candidates into the bioinformatics drug scoring and specific prediction models for gliomas.…”

Quality Control for Medicinal Plants

“…• Traditional (holistic) medicines are often mixtures, which do not fit well to the general set-up of clinical (reductionistic) trials [27,28].…”

Machine learning for LC–MS medicinal plants identification

“…(U)HPLC coupled with mass-spectrometer is now standard instrumentation for such applications [7][8][9][10][11][12], with lesser number of works considering GC-MS [13,14], NMR [15,16], IR [17][18][19], and other analytical techniques (e.g. electronic nose [14], electrophoresis [12,18,20]).…”